KATHMANDU, July 19: Production of anti-cancer drugs has been started for the first time in Nepal. Teaching Pharma Private Limited has started production of anti-cancer medicine for the first time. Nepal used to import the drugs from India and other third countries.
Shailesh Vaidya, Executive Director of Teaching Pharma, said that the production of anti-cancer drugs has been started in Nepal itself. He informed that the process of drug production has been started with the approval of the Department of Drug Administration and some drugs will reach the market commercially within a month.
TPPL starts manufacturing drugs used in treatment of cancer in...
The company has started production of anti-cancer drugs in Nepal by signing a technology transfer agreement with an anti-cancer drug manufacturing company in Hyderabad, India. A company has been set up on 16 ropanis of land in Banepa of Kavrepalanchok district and medicine production has been started with an investment of around Rs 320 million. He also said that there are immediate plans to produce five cancer-related drugs and bring more drugs later.
Executive Director Vaidya claimed that the industry is a model company of Nepal built in accordance with the GMP standard of the World Health Organization and the Drug Registration Guidance 2073. "Because of the toxicity caused by cancer drugs, it is not possible to produce other drugs in the facility where this drug is produced. Another thing is that our company has the latest and most advanced technology installed in its factory," he said.
Vaidhya said the price of his company's drugs would be cheaper than those imported from abroad. The company has also unveiled anti-cancer drugs on the occasion.
